CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project investigates converting liver cells into insulin-producing pancreatic beta cells to address diabetes treatment challenges. By understanding cellular plasticity, it aims to develop a novel cell-based therapy that could provide a sustainable solution for diabetes management.
Diabetes is a degenerative disease that affects over 350 million persons worldwide.
Type 1 and type 2 diabetes are associated with either destruction or dysfunction of pancreatic insulin-producing β cells.
Despite the availability of insulin as treatment to temporarily restore the glucostasis, this remedy is unable to avoid either the acute dangers of hypoglycemia or the long-term complications of hyperglycemia.
Eventually, the challenge of treating diabetes centers on the replacement of pancrea…
MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN IN DER HELMHOLTZ-GEMEINSCHAFT (MDC)
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
